United States Hepatitis B Market and Competitive Landscape Highlights 2010-2020: Focus on Pipeline, Epidemiology, Products, Sales, Valuations & Market Share - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "US Hepatitis B Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.

US Hepatitis B Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Hepatitis B pipeline products, Hepatitis B epidemiology, Hepatitis B market valuations and forecast, Hepatitis B products sales and competitive landscape in the US.

The research is classified into nine sections - Hepatitis B overview including etiology, pathophysiology, and diagnosis, Hepatitis B treatment options, Hepatitis B pipeline products, Hepatitis B market analysis comprising of Hepatitis B epidemiology, key products marketed for Hepatitis B, market valuations and forecast, products sales and market shares.

Research Scope:

  • Hepatitis B Pipeline: Find out the products in clinical trials for the treatment of Hepatitis B by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Hepatitis B Epidemiology: Find out the number of patients diagnosed (prevalence) with Hepatitis B in the US
  • Hepatitis B Products: Identify key products marketed and prescribed for Hepatitis B in the US, including trade name, molecule name, and company
  • Hepatitis B Product Sales: Find out the sales revenues of Hepatitis B products, both branded and generics, in the US
  • Hepatitis B Market Valuations: Find out the market size for Hepatitis B products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
  • Hepatitis B Products Market Share: Find out the market shares for key Hepatitis B products in the US

Key Topics Covered:

  1. Disease Overview
  2. Hepatitis B Treatments
  3. Hepatitis B Pipeline
  4. US Hepatitis B Epidemiology
  5. Marketed Drugs for Hepatitis B in US
  6. US Hepatitis B Market Size
  7. US Hepatitis B Products Sales
  8. US Hepatitis B Market Competitive Landscape
  9. US Hepatitis B Market Forecast

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/hm55xc/us_hepatitis_b

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Liver and Kidney Disorders Drugs, Sexual and Reproductive Health Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Liver and Kidney Disorders Drugs, Sexual and Reproductive Health Drugs